Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - GB
$ 1.39
-6.08 %
$ 2 M
Market Cap
0.0
P/E
INCOME STATEMENT
2.16 M
REVENUE
-10.1 M
OPERATING INCOME
-32.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Akanda Corp.
| Revenue | 2.16 M |
| Cost Of Revenue | 2.05 M |
| Gross Profit | 111 K |
| Operating Expenses | 3.48 M |
| Operating Income | -10.1 M |
| Other Expenses | 22.2 M |
| Net Income | -32.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 2.2 | 2.6 | 41.4 K | 2.06 K | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 2.0 | 0.6 | 0.8 | 1.81 K | 0.2 |
| Gross Profit | 0.1 | 2.0 | (0.7) | 253 | (0.2) |
| OPERATING INCOME | |||||
| Operating Expenses | 3.5 | 23.4 | 6.1 | 1.7 | 0.9 |
| Selling, General and Administrative Expenses | 5.9 | 19.8 | 5.8 | 1.4 | 0.7 |
| Research and Development Expenses | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (10.1) | (20.2) | (6.8) | (1.7) | (0.9) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0.3 | 0.1 | 1.1 | 0.6 | 0.5 |
| Total Other Income | (22.2) | 11.9 | 96.4 K | (0.6) | (0.5) |
| Pre-Tax Income | (32.3) | (8.2) | (8.1) | (2.3) | (1.4) |
| NET INCOME | |||||
| Tax Provision | 0 | (8.6) | 1.1 | 0.6 | 0.5 |
| Net Income | (32.3) | 0.4 | (9.2) | (2.9) | (1.9) |
| EPS | 7.16 | 4.59 | 128 | 40.8 | 26.1 |